JUN and neoplasm: The Q-PCR, western blot analysis and immunofluorescence staining results showed that irbesartan significantly reduced the mRNA and protein expression of c-Jun in the PDO, PDX and GEM-resistant tumor models in vitro and in vivo (Fig. 4B-F and Figs. S7 and S8).